Trimetozine
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
morpholin-4-yl-(3,4,5-trimethoxyphenyl)methanone | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | ℞ Prescription only |
Routes | Oral |
Identifiers | |
CAS number | 635-41-6 |
ATC code | None |
PubChem | CID 12478 |
ChemSpider | 11968 |
UNII | 31EPT7G9PL |
ChEMBL | CHEMBL1697853 |
Chemical data | |
Formula | C14H19NO5 |
Mol. mass | 281.304 g/mol |
SMILES
| |
Trimetozine (Opalene, Trimolide, Trioxazine) is a sedative that has been marketed in Europe since 1959.[1][2] It also has mild tranquilizing effects and has been used in the treatment of anxiety.[3][4] Its mechanism of action is unclear.[citation needed]
References
- ↑ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. p. 1932. ISBN 3-88763-075-0.
- ↑ David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.
- ↑ Taverna P, Ferrari G (June 1970). "[Clinical trial of a new tranquilizing agent: trioxazine]". Minerva Medica (in Italian) 61 (46): 2574–90. PMID 5425739.
- ↑ Shpak VM, Shcheglova AIu (August 1968). "[Trioxazine in the treatment of night anxiety in children]". Pediatriia (in Russian) 47 (8): 76–7. PMID 5730033.
|
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.